PremiumKYMR

Major deal at KYMR: $28 million insider purchase

A purchase of this magnitude, especially at a time when the biotech market has not yet fully recovered, signals an exceptionally high level of confidence in the company's development pipeline.

By the SpyStocks desk · · 1 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Good intel travels.

Share this story

Super unusual activity in a small and dangerous company!

PremiumInsidersTENX8h ago2 min read

5 investment firms cut targets, and the executive bought anyway. Since then: 92.6% increase

PremiumInsidersNIQ9h ago2 min read

Unusual insider buying alert

PremiumInsidersINBX10h ago2 min read